Qualcomm Collaborates with PAREXEL International to Power Connected Clinical Trials Qualcomm Collaborates with PAREXEL International to Power Connected Clinical Trials

19 June 2017

SAN DIEGO — June 19th, 2017 — Qualcomm Incorporated (NASDAQ: QCOM), through its subsidiary Qualcomm Life, Inc., today announced its collaboration with PAREXEL International Corporation (NASDAQ: PRXL) to expand PAREXEL’s clinical technology service offerings to include a connected sensor platform to digitize clinical trials. PAREXEL, a leading biopharmaceutical services company, is leveraging Qualcomm Life’s 2net™ medical-grade solution and ecosystem of integrated medical devices in its recently launched Patient Sensor Solution, an end-to-end services and technology solution that facilitates the remote collection of study subject data via medical devices.

“Companies across the life science industry are increasingly looking for ways to conduct clinical trials more effectively and efficiently by incorporating alternative data solutions to better meet today’s evolving regulatory and payer standards,” said Xavier Flinois, President, PAREXEL Informatics. “Qualcomm Life’s 2net connectivity solution and ecosystem of integrated medical devices provides our Patient Sensor Solution with the secure infrastructure needed to deliver greater efficiencies for sponsors, allowing them to generate clinical and quality-of-life endpoints via medical devices and distinguish treatments from competition through remote monitoring.”

PAREXEL is leveraging Qualcomm Life’s platform to securely capture, transmit, store, and visualize patient data during clinical trials. With this platform, PAREXEL aims to improve the accuracy and timeliness of data collection to maximize efficiencies, reduce costs, and gain a more holistic view of trial participants’ health. Qualcomm Life’s 2net Quality Management System is based on FDA and EU-MDD regulations, and is ISO 13485:2003 certified and designed to HIPAA privacy and security standards.

“We are honored to be working with PAREXEL, a global leader in clinical development solutions, to provide connectivity capabilities to its clinical trial platform,” said Rick Valencia, president, Qualcomm Life. “Through this collaboration, we aim to help PAREXEL in streamlining clinical trials to improve accuracies, create efficiencies for clinicians and trial participants, enabling more timely, informed care.”

About Qualcomm Incorporated

Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has 86 locations in 51 countries around the world, and had approximately 19,370 employees in the third quarter. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates. All other trademarks are the property of their respective owners.

This release contains “forward-looking” statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “intends,” “appears,” “estimates,” “projects,” “will,” “would,” “could,” “should,” “targets,” and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. Such factors and others are discussed in the section entitled “Risk Factors” of the Company’s most recent Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission, which “Risk Factors” discussion is incorporated by reference in this press release. The Company specifically disclaims any obligation to update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this press release.

2net is a trademark of Qualcomm Incorporated, registered in the United States and other countries. * 2net is a product of Qualcomm Life, Inc.

Qualcomm Announces Agreement with LifeScan Inc., a Johnson & Johnson Diabetes Care Company, to Inform Patient Care with Connected Blood Glucose Meters Qualcomm Announces Agreement with LifeScan Inc., a Johnson & Johnson Diabetes Care Company, to Inform Patient Care with Connected Blood Glucose Meters

12 June 2017

Qualcomm Life to power wireless data capture for LifeScan Inc’s OneTouch Reveal® diabetes management web app

SAN DIEGO — June 12, 2017 — Qualcomm Incorporated (NASDAQ: QCOM), through its subsidiary Qualcomm Life, Inc., announced today its agreement with LifeScan Inc., one of the Johnson & Johnson Diabetes Care Companies (JJDCC), to streamline wireless data capture from LifeScan’s OneTouch Verio Flex® blood glucose meters to physicians to enable more informed care. Qualcomm Life’s medical-grade 2net™ solution will power the connectivity for efficient, cable-free data collection.

By using Qualcomm Life’s medical-grade 2net™ solution, physicians will be able to conveniently access all of the patients’ blood glucose data from Lifescan’s OneTouch Verio Flex® blood glucose monitoring system with built-in Bluetooth® Smart Technology, which wirelessly sends data to the OneTouch Reveal® cloud-based application. Prior to leveraging Qualcomm Life’s 2net solution, the data capture process was manual and cumbersome for physicians, requiring multiple cables and software versions. This new connected diabetes care provides streamlined access to a patient’s historical and recent blood glucose levels, empowering physicians and the care team to make more proactive, informed care decisions based on data trends.

The companies plan to deploy the 2net solution to select physician offices in the Fall of 2017, and expand globally in 2018.

“Enabling timely access to blood glucose data generates actionable insights for physicians and patients for more informed diabetes care management,” said Rick Valencia, president, Qualcomm Life. “The secure, wireless data capture that 2net provides is valueable for clinicians as they seek transformative ways to treat people with diabetes efficiently and effectively across the care continuum.”

About Qualcomm

Qualcomm’s technologies powered the smartphone revolution and connected billions of people. We pioneered 3G and 4G – and now we are leading the way to 5G and a new era of intelligent, connected devices. Our products are revolutionizing industries, including automotive, computing, IoT, healthcare and data center, and are allowing millions of devices to connect with each other in ways never before imagined. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, all of our engineering, research and development functions, and all of our products and services businesses, including, our QCT semiconductor business. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

* 2net is a product of Qualcomm Life, Inc. 2net is a trademark of Qualcomm Incorporated, registered in the United States and other countries.

Qualcomm enables leading hospital in Latin America to become more connected to its patients Qualcomm enables leading hospital in Latin America to become more connected to its patients

31 May 2017

Brazil’s Hospital Unimed Recife III Utilizes Qualcomm Life’s Capsule solution to Streamline Medical Device Connectivity and Integration

SAN DIEGO — May 18, 2017 — Qualcomm Incorporated (NASDAQ: QCOM) today announced, through its subsidiary Qualcomm Life, Inc., the Company’s first Capsule™ implementation in Latin America. Qualcomm Life’s Capsule solution, is connecting and integrating medical device data at Hospital Unimed Recife III, a leading hospital system in Brazil. Yesterday during Hospitalar, a key health care event in Latin American, Hospital Unimed Recife III was awarded the top certification in HIMSS Analytics’ Electronic Medical Record Adoption Model (EMRAM), an eight-stage (zero through seven) certification process that aims to guide health care providers to digital medical record-keeping. With less than 260 hospitals having achieved Stage 7 globally, it is a distinct honor for Hospital Unimed Recife III to be the first hospital in Brazil and Latin America to be the recipient of the EMRAM Stage 7 Award.

Qualcomm Life’s Capsule solution has been integral in Hospital Unimed Recife III achieving its stage seven EMRAM certification. The Capsule solution allows for the near-real time capture of medical device data across hospital care areas and integrates directly into a local EMR from MV Sistemas to enhance clinical workflows and improve operational efficiencies.

“We’re thrilled to expand our global footprint into Latin American with a premier institution, like Hospital Unimed Recife III,” said Rick Valencia, president, Qualcomm Life. “As hospitals in the region are preparing for the digitization of data, we are uniquely positioned to provide a secure, medical grade platform for connected care in the hospital, at home and all points in-between.”

“The frequency and flow of a patient’s vital sign data in the operating room and ICU settings is especially high, so it’s critical that our patients’ data is captured and integrated reliably,” said George Trigueiro Filho, administrative director at Hospital Unimed Recife III. “Qualcomm Life’s open connected health ecosystem of 800 device interfaces and leadership in connectivity made them an obvious choice to help us integrate medical devices and clinical data across our system, to enhance patient care and reduce costs. We are honored to have achieved the EMRAM certification based on this collaboration.”

The EMRAM certification encourages hospitals to use technology to better optimize patient care, leading to improved outcomes for patients, increased efficiency within the system and reduced operating costs.

About Qualcomm Incorporated

Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

About Hospital Unimed Recife III

Hospital Unimed Recife III has been in operation since October 2011, with 202 beds and 40 ICU beds. In November 2016, it achieved Stage 7 in the HIMSS Analytics’ Electronic Medical Record Adoption Model (EMRAM), making it the first hospital in Latin America with this certification. In March 2017, the hospital was also certified by the Qmentum.

Capsule is a trademark of Capsule Technologie SAS. Capsule is a product of Qualcomm Life, Inc.

Qualcomm and Mindray France collaborate to enable alarm management Qualcomm and Mindray France collaborate to enable alarm management

02 March 2017

Medical device manufacturer will integrate data using Qualcomm Life’s Capsule solution

SAN DIEGO — February 20, 2017 — Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., is collaborating with Mindray France, one of the world’s largest medical device manufacturers, to integrate medical device data to streamline alarm management across the hospital enterprise. The two companies executed an agreement to enable Mindray France to integrate data from an expansive ecosystem of medical devices leveraging Qualcomm Life’s Capsule™ platform to deliver an alarm management solution for hospitals. Mindray France selected the vendor-neutral and open Capsule platform, to solve the interoperability challenges of integrating data from a number of different devices from various medical device manufacturers.

The frequency and number of alarms emitted from medical devices can cause a sensory overload condition described as “alarm fatigue,” where clinicians become desensitized to alarms that are frequently sounded in hospitals. To address this issue, hospitals are implementing alarm management systems that better organize alarm data from medical devices.

The collaboration between Qualcomm Life and Mindray France will integrate medical device data, using Qualcomm Life’s Capsule solution, into an alarm management system managed by Mindray France’s partner, Software Team. The agreement is the first-of-its-kind between the two companies, and will allow Mindray France to resell the Capsule solution as part of their offer. Mindray’s alarm management system has already been implemented in CHU Toulouse, France, where they are leveraging the system to notify and action alarm messages, and apply customer-defined thresholds and escalation rules.

Qualcomm Life’s open, device-agnostic Capsule platform is integrated with more than 800 medical devices from multiple manufacturers, and supports the unique needs of hospitals by integrating data emitted from various biomedical devices into downstream systems, including alarm management and EMRs, to make data more actionable for clinicians.

“Mindray France is excited to collaborate with Qualcomm Life to solve the complexities of implementing an alarm management system for hospitals across France,” said Jean-Jacques Vincent, Marketing Manager, Mindray France. “Our mission is to improve health care by optimizing and sharing medical technologies with the world, and Qualcomm Life’s open, flexible and scalable Capsule connectivity solution helps us achieve this goal.”

“Qualcomm Life is thrilled to be collaborating with a leading medical device manufacturer like Mindray to help solve the pressing issue of alarm fatigue,” said Didier Argenton, vice president, sales, Qualcomm Life. “By connecting and integrating medical device data, our aim of this collaboration is to ultimately enable actionable insights that clinicians can use to improve care.”

About Qualcomm

Qualcomm’s technologies powered the smartphone revolution and connected billions of people. We pioneered 3G and 4G – and now, we are leading the way to 5G and a new era of intelligent, connected devices. Our products are revolutionizing industries including automotive, computing, IoT and healthcare, and are allowing millions of devices to connect with each other in ways never before imagined. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, all of our engineering, research and development functions, and all of our products and services businesses, including our semiconductor business, QCT, and our mobile, automotive, computing, IoT and healthcare businesses.

To learn more, visit Qualcomm’s website, blog, Twitter and Facebook pages.

Capsule is a trademark of Capsule Technologie SAS. Capsule is a product of Qualcomm Life, Inc.

Qualcomm Contacts:

Emily Kilpatrick, Corporate Communications
Phone: 1-858-845-5959
Email: corpcomm@qualcomm.com

Jamie Eisinger, Qualcomm Life, Inc.
Phone: 1-858-845-1033
Email: jeisinge@qualcommlife.com

Sarah Wolff, Qualcomm Life, Inc.
Phone: 33 1 84 17 12 88
Email: swolff@qualcommlife.com

John Sinnott, Investor Relations
Phone: 1-858-658-4813
Email: ir@qualcomm.com

UnitedHealthcare and Qualcomm Integrate New Wearable Devices with Wellness Program; People Earn Millions of Dollars in Financial Rewards for Being Active UnitedHealthcare and Qualcomm Integrate New Wearable Devices with Wellness Program; People Earn Millions of Dollars in Financial Rewards for Being Active

03 January 2017

  • The two companies enhance and expand UnitedHealthcare Motion, a wellness program that provides financial incentives of up to $1,500 per year to employees for being more active
  • New ‘bring-your-own-device’ (BYOD) model, enabled by Qualcomm Life, allows more activity trackers to be integrated to provide program participants with access to leading wearable brands and greater choice; Fitbit Charge 2 will be the newest wearable to be integrated
  • UnitedHealthcare Motion now available to employers in 40 states, up from 12 states at launch

LAS VEGAS (Jan. 3, 2017) – UnitedHealthcare and Qualcomm Incorporated (NASDAQ: QCOM), through its wholly owned subsidiary Qualcomm Life, Inc., today announced enhancements and the expansion of UnitedHealthcare Motion™, a wellness program that provides employees with activity trackers at no additional charge and enables them to earn up to $1,500 per year by meeting certain goals for the number of daily steps.

UnitedHealthcare Motion is being showcased at the International Consumer Electronics Show (CES) 2017, the annual technology convention in Las Vegas.

The two companies introduced UnitedHealthcare Motion in 2016 as a pilot in 12 states to select employers, using Qualcomm Life’s 2net™ Platform* for medical-grade connectivity that features multiple safeguards to help keep data secure. Following the successful test, the program was expanded to 40 states and will now include access to additional customized activity trackers through a ‘bring-your-own-device’ (BYOD) model. The program is now available to self-funded employers with five or more eligible employees and companies with fully insured health plans with 101 or more eligible employees.

All UnitedHealthcare Motion devices enable employees to earn up to $4 per day in deductible credits based on F.I.T. goals, which stands for frequency of walking goals (six times per day with 300 steps within five minutes at least one hour apart), intensity (3,000 steps within 30 minutes) and tenacity (10,000 total steps each day). Employers can obtain premium savings based on program participants’ combined F.I.T. results. People who consistently achieve the F.I.T. goals tend to improve their health and reduce their medical expenses.

Qualcomm Life will leverage its global connected health ecosystem and connectivity expertise to provide secure data transfer from the devices, to the Motion app and to UnitedHealthcare. Qualcomm Life will also enable the BYOD model to allow the integration of more activity trackers into the 2net Platform and UnitedHealthcare Motion, providing participants with more choice. Integrated activity trackers will be customized to enable users to see on their wrists how they are tracking against the program’s three daily F.I.T. goals.

“The growth of UnitedHealthcare Motion showcases the value of providing companies and their employees with personalized, connected health and wellness resources,” said Richard Migliori, M.D., chief medical officer of UnitedHealth Group. “Wearable technology can help encourage employees to walk each day and earn financial rewards at the same time, using secure technology that we believe is intuitive and convenient.”

The Fitbit Charge 2™ will be the newest activity tracker integrated and validated with 2net and UnitedHealthcare Motion in this BYOD model. The custom feature can be activated during early 2017 on any Charge 2 device in market by any eligible program participant.

“As the global wearables leader, we have taken another big digital-health step forward by collaborating with UnitedHealthcare and Qualcomm Life to enable people to fulfill their fitness goals and be rewarded for living a healthier lifestyle,” said James Park, co-founder and CEO, Fitbit (NYSE: FIT). “Our team custom-designed this feature to help give UnitedHealthcare Motion program participants activity insights right on their wrists, as part of our commitment to make our products integral tools to evidence-based consumer health programs.”

Employers are expected to incorporate more than 13 million wearable and fitness tracking devices into their wellness programs by 2018, according to technology consultancy Endeavors Partners. A related study published in Science & Medicine showed people tend to overestimate how much exercise they get each week by more than 50 minutes, and they underestimate sedentary time by more than two hours, underscoring the importance of a wellness program like UnitedHealthcare Motion.

“By combining UnitedHealthcare’s leadership and pioneering pro-consumer benefit designs with Qualcomm Life’s unique ability to provide effortless connectivity across an expansive ecosystem of wearables, UnitedHealthcare Motion will continue to help engage people throughout the country with the goal of enhancing their well-being,” said James Mault, M.D., F.A.C.S., vice president and chief medical officer of Qualcomm Life.

Qualcomm Life and UnitedHealthcare at CES Qualcomm Life and UnitedHealthcare will demonstrate at CES new technologies designed to simplify the consumer health care experience by making helpful, practical information more accessible through personal technology devices such as computers, smartphones and wearables.

The two companies will give away 500 activity trackers to CES attendees as part of a fundraiser. All 500 device recipients will be encouraged to walk 10,000 steps on Saturday, Jan. 7, with the goal of collectively walking 5 million steps. As part of the walking challenge, UnitedHealthcare and Qualcomm will combine to donate $50,000 to the Boys and Girls Clubs of America. Results of the challenge will be available at www.qualcommlife.com/5millionsteps.

UnitedHealthcare Motion will be displayed at the Qualcomm booth (No. 10948) in the Central Hall of the Las Vegas Convention Center and near the Digital Health Studio Live in the Sands Expo and Convention Center. Follow along on Twitter @QualcommLife or on www.qualcommlife.com/ces2017, through the #DigitalHealthCES and #5MillionSteps hashtags or follow @myUHC on Twitter.

At CES 2017, executives from both companies will speak, including:

  • Dr. Mault will speak on a CES panel, “Prescription for Profits: The Value of Connected Health,” on Wednesday, Jan. 4, at 10:15 a.m. in the Las Vegas Convention Center, North Hall, N261. He will speak on a panel, “The Big Debate: Snake Oil or Slow Start,” on Friday, Jan. 6, at 4:30 p.m. in the Venetian, Level 4, Lando 4303.
  • Craig Hankins, UnitedHealthcare vice president of digital products, will speak on a session titled “Beyond Those 10,000 Steps” on Thursday, Jan. 5, at 3:15 p.m. in the Venetian, Level 4, Lando 4303.
  • Dr. Deneen Vojta, UnitedHealth Group executive vice president of research & development, will speak on a panel, “Tech Combats the Terrible Trio: Obesity, Diabetes and Heart Disease,” on Friday, Jan. 6, from 9:35 to 10:20 a.m. at the Venetian, Level 4, Lando 4303.
  • Dr. Migliori will provide a keynote, “Exploring the International Frontiers,” on Saturday, Jan. 7, at 11:15 a.m. in the Venetian, Level 4, Lando 4303.
  • Tom Beauregard, UnitedHealth Group executive vice president and chief innovation officer, will speak on a panel, “The Palpable Future of Workplace Wellness,” on Saturday, Jan. 7, at 11:30 a.m. in the Venetian, Level 4, Lando 4303.

About Qualcomm Incorporated

Qualcomm’s technologies powered the smartphone revolution and connected billions of people. We pioneered 3G and 4G – and now, we are leading the way to 5G and a new era of intelligent, connected devices. Our products are revolutionizing industries including automotive, computing, IoT and healthcare, and are allowing millions of devices to connect with each other in ways never before imagined. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, all of our engineering, research and development functions, and all of our products and services businesses, including our semiconductor business, QCT, and our mobile, automotive, computing, IoT and healthcare businesses. To learn more, visit Qualcomm’s website, blog, Twitter and Facebook pages.

About UnitedHealthcare

UnitedHealthcare is dedicated to helping people nationwide live healthier lives by simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. The company offers the full spectrum of health benefit programs for individuals, employers, military service members, retirees and their families, and Medicare and Medicaid beneficiaries, and contracts directly with more than 1 million physicians and care professionals, and 6,000 hospitals and other care facilities nationwide. UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified Fortune 50 health and well-being company. For more information, visit UnitedHealthcare at www.uhc.com or follow @myUHC on Twitter.

CONTACT:
Jamie Eisinger
Qualcomm Life
(831)-915-0295
jeisinge@qualcommlife.com

Will Shanley
UnitedHealthcare
(714) 204-8005
will.shanley@uhc.com

* 2net is a trademark of Qualcomm Incorporated, registered in the United States and other countries.

Philips and Qualcomm announce strategic collaboration to advance personalized connected health care Philips and Qualcomm announce strategic collaboration to advance personalized connected health care

31 August 2016

Philips HealthSuite to serve as a global, secure data storage solution for Qualcomm Life’s medical-grade 2net™ Platform. Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health.

Qualcomm Life’s 2net Platform to provide medical-grade connectivity and integration for Philips and third-party medical devices for Philips HealthSuite connected care solutions and services

Amsterdam, The Netherlands and San Diego, CA – Royal Philips (NYSE: PHG; AEX: PHIA) and Qualcomm Incorporated (NASDAQ: QCOM) through its subsidiary, Qualcomm Life, Inc., today announced a strategic technology collaboration to advance connected health across the health continuum -- from healthy living and prevention to chronic care management and home care. The companies are teaming up to leverage each other’s respective leading capabilities – Philips’ leadership in connected health informatics and regulated health care cloud data management and analytics, and Qualcomm Life’s expertise in secure, medical-grade device connectivity and integration. This collaboration will enable both companies to offer care providers enhanced, scalable, connected care solutions and services within a secure global ecosystem.

Qualcomm Life’s 2net Platform will serve as the medical device connectivity solution for Philips HealthSuite, the company’s cloud-enabled health ecosystem of devices, apps and digital tools. By joining the Qualcomm Life 2net Ecosystem, Philips provides its HealthSuite users seamless access to a wide array of connected medical devices including medication dispensers, medical grade biosensors, ventilators, blood pressure monitors, point of care self-tests, and blood glucose meters. Philips will leverage the 2net Platform to connect both Philips and third party medical devices. Secure connectivity, data capture and transmission powered by the 2net Platform, 2net Hub and 2net Mobile, will enable HealthSuite users to customize and scale connected care programs, add additional medical devices and gain a fuller patient profile over longer periods of time, with the aim to support timely intervention, assist in diagnosis, personalize treatment plans and help contribute to the goal of improving patient outcomes. An example of an implementation of this connectivity collaboration will go live shortly with Philips’ Trilogy ventilator family and Care Orchestrator care management application to advance care for patients with COPD and other respiratory conditions.

As part of the collaboration, Qualcomm Life will leverage Philips HealthSuite as a global, secure, data management and storage solution for its medical-grade 2net Platform, allowing Qualcomm Life to tap into the value of health data through data normalization, aggregation and analytics. Qualcomm Life customers can now have direct access to build applications, integrate with electronic health record systems, store normalized data, run analytics, and manage authorization and consents in a compliant and secure environment.

“As the home is fast becoming a viable care setting, care providers, home health agencies, and other institutions are increasingly using connected care to reduce emergency care, readmissions of patients with chronic diseases,” said Jeroen Tas, CEO, Connected Care and Health Informatics at Philips. “By collaborating with Qualcomm Life and leveraging its connectivity and wireless expertise, we aim to help care providers to engage better with their patients and contribute to the goal of improving outcomes. Patient self-management combined with 24/7 connectivity to a care network is an emerging model that enables scalable chronic disease management for patients and providers.”

“An undeniable leader in the health care technology industry, Philips brings a deep technology expertise to their health care initiatives, and by joining forces we aim to deliver intelligent care to patients and providers at scale,” said Rick Valencia, president, Qualcomm Life, Inc. “We are thrilled to be working with Philips, enabling Qualcomm Life to continue to grow its ecosystem and ultimately serve as the underpinning of the Internet of Medical Things.”

Jeroen Tas and Rick Valencia will deliver keynote presentations at Qualcomm Life’s connected health ecosystem conference, Connect 2016, on August 31, in San Diego, CA. For more information please visit http://www.qualcommlife.com/connect/ and follow @PhilipsLiveFrom, @QualcommLife and the event hashtag, #qualcommconnect.

Qualcomm and Boehringer Ingelheim Pharmaceuticals collaborate to add new digital technology to RESPIMAT® inhaler Qualcomm and Boehringer Ingelheim Pharmaceuticals collaborate to add new digital technology to RESPIMAT® inhaler

30 August 2016

Two industry leaders combine strengths in health care and technology to aim to improve chronic obstructive pulmonary disease (COPD) care

SAN DIEGO, CALIFORNIA AND RIDGEFIELD, CONNECTICUT — August 30, 2016 — Boehringer Ingelheim Pharmaceuticals Inc. and Qualcomm Incorporated (NASDAQ: QCOM) through its subsidiary, Qualcomm Life, Inc., today announced a new collaboration to develop a connectivity solution for the RESPIMAT inhaler, the platform inhaler for the Boehringer Ingelheim family of respiratory therapies, to help improve COPD treatment outcomes. The collaboration will be announced at Qualcomm Life’s fifth annual Connect 2016 ecosystem conference, taking place on August 30 and August 31, 2016 in San Diego, California.

“For more than 40 years, Boehringer Ingelheim has had an unwavering commitment to the COPD community to provide new health solutions that can help improve patient outcomes and expand our understanding of COPD,” said Ruchin Kansal, Executive Director and Head, Business Innovation, Boehringer Ingelheim Pharmaceuticals, Inc. “Boehringer Ingelheim is proud to join forces with Qualcomm Life, a global leader in wireless technologies, to bring the latest technology to our RESPIMAT inhaler with the goal of improving adherence to daily medicines that treat symptoms of COPD.”

“Qualcomm Life is committed to powering the Internet of Medical Things to ultimately enable intelligent care to be delivered wherever the patient may be,” said Rick Valencia, president, Qualcomm Life, Inc. “We are excited to be collaborating with an industry leader like Boehringer Ingelheim to deliver a more seamless digital health experience that can enable their COPD patients to better manage their disease.”

Through its 2net™[1] Design platform, Qualcomm Life is developing the prototype for a small, wireless, low-power, disposable module for the RESPIMAT inhaler. This fully- PC-COPD-0164-CONS integrated inhaler, which is designed to seamlessly connect with Qualcomm Life’s 2net Platform, will be able to track puffs from the RESPIMAT inhaler, and the collected information can be shared with health care providers and people who have been prescribed one of Boehringer Ingelheim’s RESPIMAT medicines.

As with other chronic diseases, poor adherence to treatment plans is common among people with COPD and can result in increased rates of COPD symptoms, health care costs, hospitalizations and even death. The collaboration seeks to combine Boehringer Ingelheim’s global leadership in discovering and developing COPD medicines with Qualcomm Life’s expertise in developing reference designs for wireless, single-use and small integrated modules to create a solution to support adherence to daily treatment regimens.

The RESPIMAT is the platform inhaler for the Boehringer Ingelheim respiratory medications. For more information about the RESPIMAT inhaler and the medicines approved for use in the RESPIMAT, please visit www.us.respimat.com.

Leveraging Qualcomm Life’s deep wireless expertise and technologies, 2net Design is a platform for designing the communications components of connected medical devices, including disposable drug delivery devices and disposable diagnostic devices for condition specific connected therapies.

[1] 2net is a trademark of Qualcomm Incorporated, registered in the United States and other countries.

Hill-Rom Introduces The VisiVest™ System, the World's First Connected Airway Clearance System Hill-Rom Introduces The VisiVest™ System, the World's First Connected Airway Clearance System

16 June 2016

System designed to build stronger connections between patients and care teams to help improve therapy adherence

CHICAGO, June 16, 2016 – Hill-Rom Holdings, Inc. (NYSE: HRC), a leading global medical technology company, today announced the introduction of the VisiVest System, a connected therapeutic solution for patients in need of airway clearance therapy. The world’s first solution combining industry leading high-frequency chest-wall oscillation (HFCWO) technology with wireless connectivity powered by Qualcomm Life, Inc., a subsidiary of Qualcomm Incorporated, the VisiVest System provides therapy adherence data that may help inform decisions caregivers make for their patients, resulting in reduced risk of respiratory infections, hospitalizations, and medical costs.

Patients’ usage data from the VisiVest System is remotely and securely transmitted to the VisiView™ Health Portal via Qualcomm Life’s 2net™ Hub enabling highly secure, medical-grade connectivity and effortless user experience. The VisiView Health Portal, developed by Razorfish, a leading application development company, then displays data trends in an easy-to-use dashboard format. This connectivity fosters a closer partnership between patients and health care teams, so treatment decisions by caregivers can be more tailored and responsive, which may result in better therapy adherence.

“In healthcare, the ability to make decisions based on accurate, timely information is essential,” saidAlton Shader, president, Front Line Care at Hill-Rom. “The VisiVest System and Qualcomm Life’s 2net connectivity solution bring care teams and patients closer, helping to better manage patients’ illness and improve their quality of life.”

“We are thrilled to be working with a global industry leader in health care technology and excited by the impact our collaboration with Hill-Rom can have for chronic lung disease patients and their caregivers,”said Rick Valencia, president, Qualcomm Life, Inc. “By combining Hill-Rom’s leadership in health care with Qualcomm Life’s expertise in connectivity, we are innovating to deliver effortless connected experiences that empower patients and their care providers.”

In a pilot study conducted over the past few months, 160 patients from seven cystic fibrosis clinics have adopted The VisiVest System. Patients and care teams have responded with great enthusiasm and excitement for the technology.

“What I like most about the VisiVest System is being able to see my patients’ session data and trends,”said Tom Newton, pulmonary therapist, Miller Children’s Hospital, Long Beach, CA. “Now I’m not just telling my patients the more adherent they are to their therapy, the higher their pulmonary function numbers are likely to be. We can actually look at their adherence score together and have a more comprehensive conversation about their numbers.”

Connected health solutions will continue to strengthen Hill-Rom’s leadership role in the respiratory care industry.

The VisiVest™ System
Hill-Rom’s VisiVest garment provides airway clearance by inflating and deflating rapidly, applying gentle pressure to the chest wall. This works to loosen and dislodge mucus from the bronchial walls and move it to larger airways where it can be cleared by coughing or suctioning. If not removed, retained secretions may contribute to increased rates of respiratory infection, hospitalization and reduced lung function.

The VisiView™ Health Portal
The VisiView Health Portal is Hill-Rom’s first digital health product designed to enhance communication between health care teams and patients. The VisiView Portal is a secure, cloud-based system that automatically receives information from respiratory care devices in a patient’s home. Patients and healthcare teams share a user-friendly dashboard to view therapy data and trends for enhanced teamwork.

About Hill-Rom Holdings, Inc.
Hill-Rom is a leading global medical technology company with approximately 10,000 employees worldwide. Hill-Rom partners with health care providers in more than 100 countries by focusing on patient- care solutions that improve clinical and economic outcomes in five core areas: AdvancingMobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, andRespiratory Health. Around the world, Hill-Rom's people, products, and programs work towards one mission: Enhancing outcomes for patients and their caregivers.

Medtronic and Qualcomm Collaborate to Aim to Improve Care and Health Outcomes for People with Type 2 Diabetes Medtronic and Qualcomm Collaborate to Aim to Improve Care and Health Outcomes for People with Type 2 Diabetes

25 May 2016

Joint Development of Future Generation Continuous Glucose Monitoring (CGM) Systems Aims to Provide Actionable Insights to Help Deliver Integrated Diabetes Care

DUBLIN AND SAN DIEGO – May 25, 2016 – Medtronic plc (NYSE:MDT) and Qualcomm Incorporated (NASDAQ:QCOM) through its wholly-owned subsidiary, Qualcomm Life, Inc., today announced a global, multi-year collaboration to jointly develop future generation continuous glucose monitoring (CGM) systems that aim to improve health outcomes for people with diabetes. By giving insights to doctors and people with type 2 diabetes concerning glucose levels, the companies intend to enable more informed care, especially for those who do not have control of their diabetes today. The collaboration seeks to leverage Medtronic’s market-leadership in diabetes management and Qualcomm Life’s expertise in developing reference designs for wireless, single-use and small integrated modules to create more affordable, easier-touse CGM systems, including a new sensor and smaller design that can provide near real-time and retrospective glucose data.

The initial focus of the collaboration will be to develop a single-use CGM system designed for broader practice by general practitioners who manage care for the vast majority of the 400 million people worldwide with type 2 diabetes. This collaboration supports Medtronic's strategy to develop comprehensive CGM solutions that not only measure glucose but enable the delivery of actionable insights to both patients and providers.

Leveraging Qualcomm Life’s deep wireless expertise and technologies, 2net™ Design is a platform for designing the communications components of connected medical devices, including disposable drug delivery devices and disposable diagnostic devices for condition specific connected therapies.

“We believe that glucose should be a vital sign of diabetes health. Professional CGM is an increasingly used diagnostic tool that empowers physicians and patients with meaningful glucose data to tackle glucose control. Our solutions go beyond delivering data and provide automated observations and clinical decision support to help create a personalized care plan,” said Laura Stoltenberg, vice president and general manager, Non-Intensive Diabetes Therapies at Medtronic. “Our vision is to transform diabetes care so people with diabetes can enjoy greater freedom and better health. We are thrilled to be collaborating with Qualcomm Life - a best-in-class leader in wireless technologies that is ahead of the curve in a rapidly changing connected world - to develop innovative and affordable CGM systems that will fundamentally change type 2 diabetes management.”

“Qualcomm Life’s connected health expertise along with our enabling 2net Connectivity Platform and 2net Design capabilities fit naturally with Medtronic’s diabetes leadership in bringing future generation CGM systems to market,” said Rick Valencia, president and general manager, Qualcomm Life, Inc. “This collaboration furthers our commitment of enabling new connected care models that liberate vital data and unlock insights to deliver intelligent care wherever the patient may be.”

Advanced CGM solutions are a critical element of an integrated care model. By building an ecosystem of industry leading partners, Medtronic aims to deliver more than just devices and provide intelligent solutions that improve outcomes, while lowering the overall cost of care.

About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and nextgeneration wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

About the Diabetes Group at Medtronic (www.medtronicdiabetes.com)
Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Qualcomm and 2net are trademarks of Qualcomm Incorporated, registered in the United States and other countries, used with permission.

Qualcomm Welcomes Jean-Claude Kyrillos as Vice President of Business Operations at Qualcomm Life Qualcomm Welcomes Jean-Claude Kyrillos as Vice President of Business Operations at Qualcomm Life

10 May 2016

SAN DIEGO — May 10, 2016 — Qualcomm Incorporated today announced that Jean-Claude Kyrillos has joined Qualcomm Life, Inc. a subsidiary of Qualcomm, as vice president of business operations, reporting directly to Rick Valencia, senior vice president and general manager of Qualcomm Life. Kyrillos will lead Qualcomm Life's global operations, driving operational excellence across Qualcomm Life and Capsule™ technology, and their leading connectivity and data management solutions that span the care continuum.

Jean-Claude “J.C.” Kyrillos brings more than 13 years of executive leadership in the medical device industry, including acute care, homecare, and diagnostics, with expertise in developing and executing operational strategies and efficiencies. He has led complex global organizations and company integrations, driving business strategies and alignment required to generate sustainable growth, competitive advantage and customer value.

"We are very pleased to welcome J.C. to Qualcomm Life. His exceptional leadership in operational management and deep experience in health care will strengthen our commercial excellence as we grow our connected health business globally" said Rick Valencia, senior vice president and general manager, Qualcomm Life. "J.C. has a proven track record of executing on operational efficiencies to successfully grow health care B2B businesses."

Prior to joining Qualcomm Life, J.C. was the worldwide vice president and general manager of BD’s (Becton, Dickinson and Company) global Infusion Solutions business (previously CareFusion). In this role, he led the overall strategy and operations of BD’s Alaris® infusion pump systems and associated technologies. Prior to joining CareFusion in 2011, J.C. was president, ResMed Ventures and Initiatives and previously Co-Leader for ResMed, Americas. J.C. serves on the Board of Directors for the San Diego Blood Bank and the Sharp Healthcare Foundation. J.C. earned a MBA from Harvard Business School and a BA with Honors in History from Colgate University.

Qualcomm is a trademark of Qualcomm Incorporated, registered in in the United States and other countries, used with permission. Capsule is a trademark of Capsule Technologie SAS.

Qualcomm Life Contact:
Jamie Eisinger
Qualcomm Life, Inc.
Phone: 1-858-845-1033
Email: jeisinge@qti.qualcomm.com

Qualcomm and UnitedHealthcare collaborate to deliver connected health solutions Qualcomm and UnitedHealthcare collaborate to deliver connected health solutions

01 March 2016

UnitedHealthcare selects Qualcomm Life as its enabling technology provider for connected health programs nationwide

SAN DIEGO — March 1, 2016 — Qualcomm Incorporated (NASDAQ: QCOM) today announced that its wholly owned subsidiary, Qualcomm Life, Inc., and UnitedHealthcare are collaborating to develop and deliver connected health solutions to consumers across the United States. This collaboration will focus on creating new UnitedHealthcare programs and services that incorporate the latest generation of wearables, medical devices and diagnostic tests that leverage Qualcomm Life’s 2net™ Platform for medical-grade connectivity.

The companies made the announcement at the industry-leading annual HIMSS conference, taking place in Las Vegas, NV, February 29 – March 4.

The first program under this new collaboration is UnitedHealthcare Motion™, a health and wellness program powered by Qualcomm Life’s 2net Connectivity Platform for employers nationwide. UnitedHealthcare Motion is designed to help plan participants become healthier and more active, while helping them pay for the cost of everyday health care. Available on a select basis to companies with 101 to 300 employees with a fully insured health plan, UnitedHealthcare Motion helps employers address rising care costs by providing employees and their covered spouses with custom-designed wearable devices that track the number of steps each user takes throughout the day, calculating the total number, frequency and intensity of the steps taken.

The data acquired from the wearable devices is then sent to the UnitedHealthcare Motion app, which is powered with seamless and secure connectivity through Qualcomm Life’s 2net Mobile connectivity platform. Employees with these wearable devices earn Health Reimbursement Account credits that can total up to $1,460 per year, based on their usage, helping to save on health care costs. Employers can also obtain premium savings based on the combined results of their program participants.

“We’re excited to collaborate with UnitedHealthcare in powering its connected care solutions, starting with the UnitedHealthcare Motion program,” said James Mault, M.D., F.A.C.S, vice president and chief medical officer, Qualcomm Life, Inc. “UnitedHealthcare’s leadership in innovation and broad reach across the United States, combined with Qualcomm Life’s medical grade connectivity solutions, enable us to deliver personalized, connected care to millions of health care consumers nationwide.”

“Qualcomm Life is the ideal collaborator to power our UnitedHealthcare Motion app,” said Sam Ho, M.D., chief medical officer, UnitedHealthcare. “Their experience in the wireless industry and leadership in connected health will help us deliver innovative health care programs and services that enable people to make a positive impact on their health and well-being.”

Qualcomm Life and UnitedHealthcare at HIMSS 2016
Qualcomm Life and UnitedHealthcare will demonstrate the UnitedHealthcare Motion app in Qualcomm Life’s booth 6437 at HIMSS 2016. Qualcomm Life and its subsidiary, Capsule, will also demonstrate their leading connectivity and integration solutions for medical devices in the hospital, at home and all points in between.

Follow along for updates on Twitter @QualcommLife and @myUHC and through the #HIMSS16 hashtag.

About UnitedHealthcare
UnitedHealthcare is dedicated to helping people nationwide live healthier lives by simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. The company offers the full spectrum of health benefit programs for individuals, employers, military service members, retirees and their families, and Medicare and Medicaid beneficiaries, and contracts directly with more than 1 million physicians and care professionals, and 6,000 hospitals and other care facilities nationwide. UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified Fortune 50 health and well-being company. For more information, visit UnitedHealthcare at www.uhc.com or follow @myUHC on Twitter.

About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

Qualcomm Life, Inc. Qualcomm and 2net are trademarks of Qualcomm Incorporated, registered in in the United States and other countries, used with permission.

Qualcomm Contacts:
Emily Kilpatrick, Corporate Communications
Phone: 1-858-845-5959
Email: corpcomm@qualcomm.com

Jamie Eisinger
Qualcomm Life, Inc.
Phone: 1-858-845-1033
Email: jeisinge@qti.qualcomm.com

Warren Kneeshaw, Investor Relations
Phone: 1-858-658-4813
Email: ir@qualcomm.com

UnitedHealthcare Contact:
Will Shanley
Phone: 1-714-204-8005
Email: will.shanley@uhc.com

Qualcomm Expands Collaboration with Novartis for Connected COPD Therapy Qualcomm Expands Collaboration with Novartis for Connected COPD Therapy

05 January 2016

Novartis selects Qualcomm Life and its 2net technology to digitize its clinical trials

SAN DIEGO — January 5 — Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., has been selected by Novartis, a global pharmaceutical leader, as a global digital health collaborator for its Trials of The Future program. Qualcomm Life’s 2net™ Platform will serve as a global connectivity platform for collecting and aggregating medical device data during clinical trials to improve the convenience and speed of capturing study participant data and test results to ultimately gain more trial efficiencies and connected experiences for participants.

The Trials of The Future program is designed to leverage health care technology to improve the experience of clinical trial participants and patients using Novartis products, and provide connectivity with future products marketed by Novartis. Novartis will combine the 2net Platform, 2net Hub and 2net Mobile technologies with designated medical devices to automate the collection of vital patient data at patient’s homes during clinical trials.

“Novartis is a pioneer in putting technology to use in advancing pharmaceutical innovation,” said Rick Valencia, senior vice president and general manager, Qualcomm Life. “Standardizing on the tech-agnostic 2net Platform and accessing the robust ecosystem of integrated medical devices will provide them a great range of flexibility and scalability, ultimately accelerating their efforts to design more efficient, cost-effective clinical trials.”

Novartis is using the 2net Platform in a recently-launched clinical study, evaluating the use of mobile devices with chronic lung disease patients. The study, which is observational in nature and does not involve any Novartis pharmaceutical product, leverages 2net Mobile-enabled smartphones and 2net Hubs to seamlessly collect and aggregate biometric data from medical devices and transmits this data to the cloud-based 2net Platform, which securely sends the data to the study coordinator.

Qualcomm Life to Have Significant Presence at CES 2015
Qualcomm Life will showcase chronic care and transitional care management demos at booth #8525 in Central Hall, Las Vegas Convention Center. James Mault, MD, F.A.C.S., vice president and chief medical officer, Qualcomm Life, will participate in a fireside chat on what is new in Quantified Self from 3:30-4:30 p.m. in the Las Vegas Convention Center Room, N621 on Monday, January 5. Rick Valencia, senior vice president and general manager, Qualcomm Life, will participate in a fireside chat with Corinne Savill, head of business development and licensing, Novartis, titled “Pharma goes Techy and Consumers Score” from 9:40-10:04 a.m. at the Digital Health Summit at the Venetian level 2 Bellini Room 2004 on Thursday, January 8.

About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 25 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

Qualcomm Contacts:
Emily Kilpatrick, Corporate Communications
Phone: 1-858- 845-5959
Email: corpcomm@qualcomm.com

Jamie Eisinger, Qualcomm Life, Inc.
Phone: 1-858- 845-1033
Email: jeisinge@qti.qualcomm.com

Warren Kneeshaw, Investor Relations
Phone: 1-858- 658-4813
Email: ir@qualcomm.com

Qualcomm and 2net are trademarks of QUALCOMM Incorporated, registered in the United States and other countries. Other product and brand names may be trademarks or registered trademarks of their respective owners.

Qualcomm announces collaboration with VRI to power scalable chronic care management solution Qualcomm announces collaboration with VRI to power scalable chronic care management solution

09 November 2015

Qualcomm to showcase its technology platforms and provide keynote address at mHealth Summit 2015

Qualcomm Incorporated today announced that its subsidiary, Qualcomm Life, Inc., is collaborating with VRI to develop chronic care management solutions powered by Qualcomm Life’s 2netTM Platform. The company will leverage the 2net Platform and Hub to seamlessly and securely transfer biometric data into their existing remote patient monitoring programs. The collaboration was announced at the seventh annual mHealth Summit, taking place November 8 through November 11, 2015, in Washington, D.C.

“We are excited to continue growing our ecosystem and working with innovative companies like VRI,” said Rick Valencia, senior vice president and general manager, Qualcomm Life. “Together, we are helping shape a new standard of care for chronic care management and remote patient monitoring. This post-acute care segment is exceptionally important for improving outcomes and reducing unnecessary hospitalizations.”

VRI, a health care services company with more than 25 years of experience in health monitoring, is one of the largest providers of telemonitoring, medication adherence and medical alert systems in the country. VRI’s monitoring services enable seniors, the chronically ill and people with disabilities to maintain their independence and avoid long-term care facilities and hospitalization. The program includes patients with diabetes, heart failure, hypertension, COPD and asthma. VRI selected Qualcomm Life as their preferred long-term vendor, and plan to scale their remote monitoring programs leveraging Qualcomm Life’s 2net Platform and open ecosystem approach, ultimately enabling the company to reach millions of patients living with chronic conditions.

“Qualcomm Life’s open ecosystem approach and leadership in wireless health care will allow VRI to scale our remote monitoring programs with large customers and populations,” said Chris Hendriksen, CEO, VRI. “By expanding our collaboration to include Qualcomm Life as a preferred vendor, we are able to offer remote monitoring services to more patients who can benefit the most – the chronically ill – to help improve outcomes and reduce overall costs.”

Qualcomm Life to have Significant Presence at mHealth Summit 2015
Qualcomm Life is hosting its 6th annual Ecosystem Pavilion (booth #1003), showcasing connected health solutions that can reduce the cost and complexity of care in the hospital, at home and all points in between. The ecosystem members exhibiting in the pavilion are comprised of health care providers, retail pharmacies and medical device manufacturers that are leveraging Qualcomm Life’s technology solutions to unlock the power of medical device data through seamless data connectivity and information management.

James Mault, MD, F.A.C.S., vice president and chief medical officer, Qualcomm Life, will present the Executive Spotlight Keynote entitled, “Internet of Medical Things™: Making intelligent care everywhere a reality” on November 9 at 9:15 a.m. in the Potomac Ballroom.

All rights reserved. Qualcomm and 2net are trademarks of Qualcomm Incorporated, registered in the United States and other countries, used with permission. 2net is a product of Qualcomm Life, Inc.

Qualcomm Acquires Capsule Technologie

14 September 2015

Powering medical-grade connectivity and interoperability in the hospital, at home and all points in between -

SAN DIEGO — September 14, 2015 — Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., has acquired Capsule Technologie, a leading global provider of medical device integration and clinical data management solutions with more than 1,930 hospital clients in 38 countries. Capsule will become a wholly owned subsidiary of Qualcomm Life.

The acquisition of Capsule extends Qualcomm Life’s connected health offerings into the hospital, ultimately creating a more seamless care continuum from hospital to home and all points in between. By combining Qualcomm Life’s wireless expertise and ecosystem of connected medical devices outside of the hospital with Capsule’s leadership for connecting medical devices, EMR’s and IT systems across the hospital enterprise, Qualcomm Life is creating one of the world’s largest open connected health ecosystems to deliver intelligent care everywhere.

Capsule’s leading medical device integration and clinical data management platform enables data collection, EMR and health IT system integration and monitoring in one of the largest ecosystems of connected devices inside the hospital. Capsule’s smart networking goes beyond device integration by delivering timely clinical data to various in-hospital decision support systems, alarm and notification systems and asset management tools, which help reduce latency and transcription errors to ensure timely, informed care.

“Qualcomm is focused on strengthening its position in specific Internet of Everything verticals, like healthcare,” said Derek Aberle, president, Qualcomm Incorporated. “The acquisition of Capsule expands the breadth of our healthcare platform, enabling us to provide connectivity solutions for the entire care continuum and create one of the world’s largest connected health ecosystems. This will be an important step in advancing the Internet of Medical Things.” “As health care continues to move into the home and ambulatory settings and outside of traditional care areas such as the hospital, the convergence of medical device data from wherever the patient is located is critically important,” explained Gene Cattarina, CEO, Capsule.

“Together, Qualcomm Life and Capsule will power this convergence by making data more accessible and interoperable among care teams to provide true continuity of care at the hospital, in the home and at all points in between.”

About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

This news release contains forward-looking statements that are subject to risks, uncertainties and assumptions. Actual results could differ materially from those expressed or implied by such forward-looking statements. All statements other than those of historical fact could be deemed forward-looking statements, including but not limited to statements regarding: the expected benefits of the transaction; management plans relating to the transaction; the plans, strategies and objectives of management for future operations; product development, product extensions, product integration, new products, sales channels and customers, complementary product offerings and growth opportunities in certain business areas, including the Internet of Medical Things; the potential future financial impact of the transaction; and any assumptions underlying any of the foregoing. Actual results may differ materially from those referred to in the forward-looking statements due to a number of important factors, including but not limited to the possibility that expected benefits of the transaction may not materialize as expected; that Qualcomm Life may not be able to successfully integrate the products and employees of Capsule or ensure the continued performance or growth of Capsule’s products; as well as the other risks detailed from time to time in Qualcomm’s SEC reports, including its most recent Quarterly Report on Form 10-Q for the period ended June 28, 2015. Qualcomm does not undertake any obligation to update, or continue to provide information with respect to, any forward-looking statement, whether as a result of new information, future events or otherwise.

Qualcomm Contacts:
Emily Kilpatrick, Corporate Communications
Phone: 1-858-845-5959
Email: corpcomm@qualcomm.com

Jamie Eisinger, Qualcomm Life, Inc.
Phone: 1-858-845-1033
Email: jeisinge@qti.qualcomm.com

Warren Kneeshaw, Investor Relations
Phone: 1-858-658-4813
Email: ir@qualcomm.com

Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 Qualcomm Life Announces New Connected Health Collaborations at Connect 2015

31 August 2015

2net™ and HealthyCircles™ Power Chronic Care Management solutions for Healthcare Partners and P2Link

SAN DIEGO — August 31, 2015 — Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., is collaborating with Davita Healthcare Partners and P2Link to develop chronic care management solutions powered by Qualcomm Life’s 2netTM Device Connectivity Platform and HealthyCirclesTM Care Coordination Platform to enable continuous care, informed interventions and better management of at-risk populations. The collaborations were announced at Qualcomm Life’s annual Connect 2015 ecosystem conference taking place on August 31 and September 1, 2015 in San Diego, California.

Davita HealthCare Partners, one of the largest medical groups and physician network operators, provides integrated care management for approximately 830,000 patients, more than 600,000 of which live in California and represent diverse cultures, socioeconomic groups, ages, and health statuses. The company will integrate Qualcomm Life’s 2net Mobile and HealthyCircles technologies into a coordinated care program for patients with heart failure (HF). Patients will be equipped with a home blood pressure monitor, a weight scale and a tablet powered by 2net Mobile to seamlessly collect and transmit the biometric data to the cloud. Patients will also leverage the HealthyCircles Platform to monitor the patient’s health status at home, receive relevant educational content and targeted, proactive care management interventions. The initial program will roll out in Q4 2015.

“We are excited to be working with Qualcomm Life on our chronic care management programs,” said Doug Allen, MD, MMM, senior vice president, Clinical Informatics, DaVita HealthCare Partners. “Their expertise in wireless, open ecosystem approach and robust care coordination capabilities make them an ideal partner as we seek to expand our capabilities in the delivery of optimal care to patients with chronic disease, in the comfort of their own homes.”

P2Link, a provider of innovative health monitoring solutions, enables payors and providers to reduce costs while improving quality of care for patients with heart failure and chronic obstructive pulmonary disease (COPD). The company is collaborating with Qualcomm Life in the United States and Europe to deploy remote monitoring medical device kits powered by the 2net Hub and Platform for patients suffering from HF and COPD, with the first patient enrollment expected to begin in the United States in Q4 2015. Through their pay-forperformance services that leverage proprietary predictive models and an in-house clinical call center, P2Link targets to reduce the cost of care for HF and COPD patients by 10 to 15 percent, helping payors and providers as they transition to a value-based reimbursement system.

“Qualcomm Life’s 2net technology enables seamless capture of medical device data from the patient’s home, ultimately allowing our team to better manage at-risk patient populations while generating the savings expected by the payors and care providers we serve.” said Nabil Mouline, chief operating officer, P2Link.

P2Link’s first implementation of 2net will be with Emerson Hospital in Concord, Massachusetts. “P2Link’s services powered by Qualcomm Life’s 2net technology will help institutions like ours capture the promise of the ‘triple aim’: a better care experience, improved health outcomes and lowered costs for the 300,000 individuals to whom we provide Premium Care with a Personal Touch” said Jack Wilhelm, senior vice president, Administration of Emerson Hospital.

“With our growing ecosystem of more than 500 companies, we are collaborating to develop new care models that deliver near real-time informed care that’s both adaptive and patient-centered,” said Rick Valencia, senior vice president and general manager, Qualcomm Life. “We are thrilled to be working with HealthCare Partners and P2Link to deliver the right care, at the right time, in the right location to the patients who need it the most.”

Sponsored by GlobalLogic, LenovoHealth, Triventis Health, Striiv, vitaphone e-health solutions, DLA Piper, Orion Health and Accenture Intelligent Patient Solutions, the fourth annual Connect 2015 welcomes leaders from across the connected health industry to discuss scalable patient centered care and cost-effective management of at-risk patient populations. Speakers include Dr. Eric Topol, director of the Scripps Translational Science Institute, Mick Farrell, chief executive officer, ResMed, Adam Pellegrini, vice president of eHealth, Walgreens, Sandra Elliott, vice president of Consumer Technology and Service Development, Meridian Health and many more. The full conference agenda can be found here. For updates and to join real-time conversations from Connect 2015, follow @QualcommLife and #QualcommConnect on Twitter and visit the new Qualcomm Life Storify page.

About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 25 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.

Qualcomm and 2net are trademarks of QUALCOMM Incorporated, registered in the United States and other countries. HealthyCircles is a trademark of MyTeleHealth Solutions, LLC, a wholly owned subsidiary of Qualcomm Life, Inc. Other product and brand names may be trademarks or registered trademarks of their respective owners.

The 2net services are offered through Qualcomm Life, Inc. Available in the United States, Canada and the European Union. Wireless network coverage may vary. Medical device depicted may not be available at the time of this publication. Nothing in these materials is an offer to sell any of the components or devices referenced herein.

Qualcomm Contacts:
Emily Kilpatrick, Corporate Communications
Phone: 1-858-845-5959
Email: corpcomm@qualcomm.com

Jamie Eisinger, Qualcomm Life, Inc.
Phone: 1-858-845-1033
Email: jeisinge@qti.qualcomm.com

Warren Kneeshaw, Investor Relations
Phone: 1-858-658-4813
Email: ir@qualcomm.com

[12 3  >>